November 2026 Trial Snapshot
💻
Best viewed on desktop
The ALS trial snapshot includes an interactive map and data tables that work best on a larger screen.
Read the ALS research guide →Active sponsors
Trials
A Study of Single Ascending Doses of NI112 in Adults With Amyotrophic Lateral Sclerosis (ALS)
Register for Medical Data, Functional Scales, and Care Outcomes in ALS, SMA, and Other Motor System Disorders
A Study to Learn About the Safety of BIIB147 and Its Effects in Adults With Amyotrophic Lateral Sclerosis (ALS)
A Study of LY3873862 in Participants With Sporadic or Familial Amyotrophic Lateral Sclerosis (ALS).
Brain-Computer Interface Communication Device for People With ALS
Safety, Tolerability, and Pharmacodynamic Exploration of Orelabrutinib in Patients With Amyotrophic Lateral Sclerosis (ALS)
PhiCube for Bilateral Upper Limb Neuromotor and Cognitive Rehabilitation in Adults
Early Access Program for Ulefnersen in Children, Adolescents and Adults With FUS-associated Amyotrophic Lateral Sclerosis (FUS-ALS)
Anticipated Patient and Caregiver Burden
TP04HN106 in the Treatment of Patients With Amyotrophic Lateral Sclerosis
Showing trials with activity in the past 30 days. See the full ALS research landscape →
Recently completed · awaiting results
Edinburgh Cognitive and Behavioural Amyotrophic Lateral Sclerosis Screen in Norway: A Prospective Cohort Study
Condition guide
ALS — the full picture
Research landscape, trial types, and what eligibility typically looks like — written for patients but useful for everyone.
Monthly digest
Get this brief every month
We’ll email you the ALSbrief as soon as it’s published — no login required.
Coming soon